Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel membrane bioreactor method ensures high purity Ezetimibe intermediate with reduced costs and scalable production for global pharmaceutical supply chains.
Novel Grignard-based route eliminates palladium catalysts, reducing costs and improving supply chain reliability for high-purity eczema treatment intermediates.
Patent CN111333495B discloses a potent antitumor benzophenone. Efficient Eaton reagent synthesis offers cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102250005A details a novel chiral catalytic hydrogenation route for Eslicarbazepine, offering superior atom economy and simplified purification for API manufacturing.
Advanced synthesis method for cis-perhydroisoindole using lithium borohydride offers significant cost and safety advantages for pharmaceutical intermediate supply chains globally.
Patent CN103467567B reveals high-yield synthesis for metalloprotease substrates. Enhances supply chain reliability and reduces manufacturing complexity for research teams.
Patent CN116103255A details engineered KdAKR mutants for high-yield synthesis of tert-butyl 6-chloro-(3R,5S)-dihydroxyhexanoate, offering superior stereoselectivity and thermal stability for statin production.
Patent CN112110969B details a novel route for 3-nitro-7-azaindole triazole glycosides. Discover cost-effective synthesis and supply chain advantages for oncology APIs.
Novel Zn-N complex enables 99% transformation efficiency in Henry reactions. Reduces heavy metal waste significantly. Reliable supplier for high-purity pharma intermediates.
Patent CN112062835B details a novel solid-phase method for Bivalirudin, achieving >99.8% purity. Ideal for reliable API intermediate suppliers seeking scalable production.
Discover the novel synthesis of 3-nitro-7-azaindole triazole glycosides. A scalable, metal-free route for antiviral and anticancer pharmaceutical intermediates with improved solubility.
High-yield synthesis of 5α-androst-7-methyl intermediates via catalytic hydrogenation and Wittig reaction. Reliable supply chain for steroid manufacturing.
Patent CN101921275B reveals a streamlined Imipenem manufacturing route featuring solvent clathrate technology, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN105189524A enables high-yield chiral amino acid production with recoverable auxiliaries for scalable pharmaceutical manufacturing supply chains and cost-effective commercialization strategies.
Patent CN104829672A reveals efficient tetrahydrofuran synthesis. Reduces costs and improves purity for reliable pharmaceutical intermediate supply chains globally.
Patent CN101503365A details a mild NaBH4/I2 reduction for Venlafaxine intermediates, offering high purity and cost-effective scalable manufacturing for global supply chains.
Novel patent CN103012328B offers high-yield Cabazitaxel synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Novel chiral N-heterocyclic carbene catalyst improves yield and dr value in asymmetric reactions, offering cost-effective solutions for pharmaceutical manufacturing.
Novel anti-inflammatory intermediate synthesis via cyclization. Offers high purity, scalable route from turpentine derivatives for cost-effective pharmaceutical manufacturing.
Patent CN108948034B reveals a novel tandem reaction for high-purity isoindolinone derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.